Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$8.55 – $16.78
10% from low
Exchange
OTC Link
ADRC
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.61B | $2.82B | $3.57B | $4.01B | $4.44B | $4.78B | $5.39B | $5.69B |
| Cost of revenue | $1.06B | $1.18B | $1.35B | $1.51B | $1.89B | $2.06B | $2.19B | $2.50B |
| Gross profit | $1.55B | $1.64B | $2.21B | $2.50B | $2.55B | $2.71B | $3.20B | $3.18B |
| Gross margin | 59.4% | 58.0% | 62.0% | 62.4% | 57.5% | 56.8% | 59.4% | 56.0% |
| R&D | $111.0M | $103.0M | $157.0M | $225.0M | $281.0M | $295.0M | $325.0M | $129.0M |
| Operating income | $563.0M | $499.0M | $428.0M | $340.0M | $144.0M | $302.0M | $645.0M | $738.4M |
| EBITDA | $683.0M | $542.0M | $599.0M | $500.0M | $492.0M | $644.0M | $682.0M | $1.09B |
| Net income | $337.0M | $317.0M | $241.0M | $247.0M | $93.0M | $168.0M | $235.0M | $573.6M |
| Net margin | 12.9% | 11.2% | 6.8% | 6.2% | 2.1% | 3.5% | 4.4% | 10.1% |
| EPS (diluted) | 1.36 | 1.28 | 0.97 | 0.98 | 0.37 | 0.64 | 0.88 | 2.15 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $6.5B | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $7.2B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
AMBU A S UNSP/ADR
No one on the platform currently holds AMBBY.
No tracked institution reports a position in AMBBY as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-05 | $0.0639 | 2025-12-22 |
| 2024-12-06 | $0.0538 | 2024-12-23 |
| Execution date | Ratio |
|---|---|
| 2018-01-24 | 1.25-for-1 |
No one on the platform has traded AMBBY yet.
| $2.6B |
| — |
| CZMWYCarl Zeiss Meditec AG | $30.38 | -1.94% | $2.7B | — |
| GNGBFGetinge AB (publ) | $20.05 | +0.00% | $5.1B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 6.8× earnings vs its 21.1× historical median P/E.
Fair value ≈ $29.05 · price $9.38 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.